Works by Kawano, Haruna
Results: 21
A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 12, p. 1292, doi. 10.1007/s10157-021-02097-6
- By:
- Publication type:
- Article
Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 5, p. 467, doi. 10.1007/s10157-020-02009-0
- By:
- Publication type:
- Article
Novel semi-automated kidney volume measurements in autosomal dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 3, p. 583, doi. 10.1007/s10157-017-1486-6
- By:
- Publication type:
- Article
A potentially crucial role of the <italic>PKD1</italic> C-terminal tail in renal prognosis.
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 2, p. 395, doi. 10.1007/s10157-017-1477-7
- By:
- Publication type:
- Article
Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 6, p. 1199, doi. 10.1007/s10157-015-1101-7
- By:
- Publication type:
- Article
Exploring urinary biomarkers in autosomal dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 5, p. 968, doi. 10.1007/s10157-014-1078-7
- By:
- Publication type:
- Article
The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial.
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 5, p. 867, doi. 10.1007/s10157-015-1086-2
- By:
- Publication type:
- Article
PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 7, p. 1020, doi. 10.3390/biom13071020
- By:
- Publication type:
- Article
Aberrant differentiation of Tsc2-deficient teratomas associated with activation of the mTORC1-TFE3 pathway.
- Published in:
- Oncology Reports, 2015, v. 34, n. 5, p. 2251, doi. 10.3892/or.2015.4254
- By:
- Publication type:
- Article
Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP).
- Published in:
- Clinical & Experimental Nephrology, 2024, v. 28, n. 10, p. 1004, doi. 10.1007/s10157-024-02509-3
- By:
- Publication type:
- Article
Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2024, v. 28, n. 1, p. 82, doi. 10.1007/s10157-023-02426-x
- By:
- Publication type:
- Article
Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2023, v. 27, n. 10, p. 809, doi. 10.1007/s10157-023-02372-8
- By:
- Publication type:
- Article
Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 21, p. 6528, doi. 10.3390/jcm11216528
- By:
- Publication type:
- Article
Clinical Practice Guidelines for tuberous sclerosis complex‐associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 10, p. 808, doi. 10.1111/iju.15213
- By:
- Publication type:
- Article
Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-35790-5
- By:
- Publication type:
- Article
Establishment of Tsc2-deficient rat embryonic stem cells.
- Published in:
- International Journal of Oncology, 2015, v. 46, n. 5, p. 1944, doi. 10.3892/ijo.2015.2913
- By:
- Publication type:
- Article
High prevalence of frailty in patients with lower urinary tract symptoms.
- Published in:
- Geriatrics & Gerontology International, 2023, v. 23, n. 8, p. 609, doi. 10.1111/ggi.14633
- By:
- Publication type:
- Article
Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0166288
- By:
- Publication type:
- Article
Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2088, doi. 10.3390/ijms25042088
- By:
- Publication type:
- Article
Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 10, p. 1259, doi. 10.1007/s10147-023-02372-4
- By:
- Publication type:
- Article
Imaging Identification of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease: Simple Eligibility Criterion for Tolvaptan.
- Published in:
- American Journal of Nephrology, 2020, v. 51, n. 11, p. 881, doi. 10.1159/000511797
- By:
- Publication type:
- Article